Medidata Solutions Inc (MDSO)

56.92
0.18 0.32
NASDAQ : Technology
Prev Close 57.10
Open 57.15
Day Low/High 56.57 / 57.47
52 Wk Low/High 30.22 / 54.99
Volume 72.62K
Avg Volume 442.00K
Exchange NASDAQ
Shares Outstanding 57.71M
Market Cap 3.27B
EPS 0.50
P/E Ratio 110.96
Div & Yield N.A. (N.A)

Latest News

Medidata And Medical Device Innovation Consortium Partner To Help Drive Change In The Medical Technology Space

Medidata And Medical Device Innovation Consortium Partner To Help Drive Change In The Medical Technology Space

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that the company has joined the Medical Device Innovation Consortium (MDIC), a...

Medidata To Present At Upcoming Investor Conferences

Medidata To Present At Upcoming Investor Conferences

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that the company will present at the following upcoming investor conferences.

Medidata Reports Record Full-Year And Fourth Quarter 2016 Results

Medidata Reports Record Full-Year And Fourth Quarter 2016 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the fourth quarter and full-year 2016 and provided detailed...

Medidata To Expand Its Industry-Leading Cloud Platform With Regulated Content And Document Management Capabilities

Medidata To Expand Its Industry-Leading Cloud Platform With Regulated Content And Document Management Capabilities

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that it plans to add regulated content and document management capabilities to the...

Medidata Schedules Fourth Quarter Earnings Conference Call For February 9, 2017

Medidata Schedules Fourth Quarter Earnings Conference Call For February 9, 2017

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its fourth quarter 2016 financial results before the open of the...

First Week of MDSO March 17th Options Trading

First Week of MDSO March 17th Options Trading

Investors in Medidata Solutions, Inc. saw new options become available this week, for the March 17th expiration.

Interesting MDSO Put And Call Options For February 17th

Interesting MDSO Put And Call Options For February 17th

Investors in Medidata Solutions, Inc. saw new options become available this week, for the February 17th expiration.

Celgene Increases Adoption Of Medidata Clinical Cloud®, Gaining Further Value From Implementation Of Medidata's Strategic Monitoring And Data Analytics Solutions

Celgene Increases Adoption Of Medidata Clinical Cloud®, Gaining Further Value From Implementation Of Medidata's Strategic Monitoring And Data Analytics Solutions

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Celgene Corporation has expanded its adoption of the Medidata Clinical Cloud ®...

Medidata To Present At J.P. Morgan 35th Annual Healthcare Conference

Medidata To Present At J.P. Morgan 35th Annual Healthcare Conference

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann, chief financial officer, will present at the J.

Medidata Payments Wins Scrip Award For Best Sponsor-Focused Technological Development In Clinical Trials

Medidata Payments Wins Scrip Award For Best Sponsor-Focused Technological Development In Clinical Trials

Medidata (NASDAQ:MDSO) is pleased to announce that its global site payment technology, Medidata Payments, was recognized as the 2016 "Best Technological Development in Clinical Trials - Sponsor Focused" by SCRIP...

Medidata To Present At Piper Jaffray Healthcare Conference

Medidata To Present At Piper Jaffray Healthcare Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann, chief financial officer, will present at the 28 th Annual...

Medidata Introduces EConnect Partner Program

Medidata Introduces EConnect Partner Program

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced the launch of the Medidata eConnect Partner Program.

Medidata Honors Chiltern With Inaugural Architect Of Hope Award, Celebrating Innovation In Life Sciences

Medidata Honors Chiltern With Inaugural Architect Of Hope Award, Celebrating Innovation In Life Sciences

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to announce that Chiltern, a leading global contract research organization (CRO), is one of...

French Biopharma Invests In Medidata Technology To Drive Cutting-Edge Cancer And Rare Disease Research

French Biopharma Invests In Medidata Technology To Drive Cutting-Edge Cancer And Rare Disease Research

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Erytech Pharma ("Erytech"), a French biopharmaceutical company developing...

Medidata To Host Financial Analyst Day In New York City On November 18

Medidata To Host Financial Analyst Day In New York City On November 18

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will host a financial analyst day on Friday, November 18, 2016 in New York City.

Japan's Nobelpharma Selects Medidata As Technology Partner For New Clinical Study On Sleep Disorders

Japan's Nobelpharma Selects Medidata As Technology Partner For New Clinical Study On Sleep Disorders

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that the Medidata Clinical Cloud ® has been adopted by Nobelpharma to...

Medidata Reports Record Third Quarter 2016 Results

Medidata Reports Record Third Quarter 2016 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the third quarter of 2016.

LifeMap Solutions Joins Medidata AppConnect Partner Program To Drive MHealth Innovation

LifeMap Solutions Joins Medidata AppConnect Partner Program To Drive MHealth Innovation

LifeMap Solutions, the digital health subsidiary of BioTime, Inc. (NYSE MKT: BTX), today announced a partnership with Medidata (NASDAQ: MDSO), the leading provider of cloud-based solutions for clinical research.

Medidata Unveils AppConnect Partner Program

Medidata Unveils AppConnect Partner Program

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the launch of its AppConnect Partner Program in support of mobile health (mHealth)...

Medidata Schedules Third Quarter Earnings Conference Call For October 25, 2016

Medidata Schedules Third Quarter Earnings Conference Call For October 25, 2016

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its third quarter 2016 financial results before the open of the...

Society For Clinical Research Sites And Medidata Launch Advisory Group In Support Of Clinical Trial Investigators And Research Sites

Society For Clinical Research Sites And Medidata Launch Advisory Group In Support Of Clinical Trial Investigators And Research Sites

The Society for Clinical Research Sites (SCRS) and global clinical trial technology and data analytics leader Medidata (NASDAQ:MDSO) today announced the launch of a clinical trial Site Advisory Group (SAG).

Polaris Pharmaceuticals Adopts Medidata Payments

Polaris Pharmaceuticals Adopts Medidata Payments

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that multinational pharmaceutical company Polaris Pharmaceuticals, Inc.

University Of North Carolina Wilmington Partners With Medidata To Bring Clinical Cloud Technology To The Classroom

University Of North Carolina Wilmington Partners With Medidata To Bring Clinical Cloud Technology To The Classroom

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and the University of North Carolina Wilmington (UNCW) have announced a new partnership to educate...

Medidata To Present At Deutsche Bank 2016 Technology Conference

Medidata To Present At Deutsche Bank 2016 Technology Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer,...

Medidata And Techfields Launch MHealth Stroke Study

Medidata And Techfields Launch MHealth Stroke Study

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, announced today that Techfields Pharma ("Techfields") has selected the Medidata Clinical...

Medidata And SHYFT Analytics Form Commercial Partnership

Medidata And SHYFT Analytics Form Commercial Partnership

Medidata (NASDAQ:MDSO) and SHYFT Analytics (SHYFT) today announced a strategic commercial partnership to increase access to healthcare data analytics in clinical trials.

Medidata To Present At Citi 2016 Global Technology Conference

Medidata To Present At Citi 2016 Global Technology Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Mike Capone, chief operating officer, and Rouven Bergmann, chief financial officer,...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ASFI, BCOM, CDOR, CYBE, MDSO, RELL, SQM, TRNC Downgrades: LPNT Initiations: None Read on to get TheStreet Quant Ratings' detailed report: